VANCOUVER, Dec. 5, 2011 /PRNewswire/ -Heart Force Medical Inc., a Vancouver-based company that has developed a non-invasive cardiac assessment, monitoring and screening device, is pleased to announce that Dr. Jonathan Steinberg, M.D., F.A.C.C. has agreed to join the Company’s Clinical Advisory Board.
Dr. Jonathan Steinberg is a cardiologist, heart rhythm specialist, and Professor of Medicine at Columbia University, College of Physicians and Surgeons of New York. He also serves as the Director, Arrhythmia Institute at Valley Health System in New York and New Jersey. Dr. Steinberg has also served his Fellowship of Cardiac Electrophysiology at Columbia Presbyterian Hospital in New York. He is leading several international research studies. His clinical activities and research focus on identifying people at risk for serious heart rhythm problems, the optimal treatment of these conditions, and the use of device therapy for treating heart failure. Dr. Steinberg has authored or co-authored in over 400 articles, book chapters, and abstracts, including publications in leading medical journals such as the New England Journal of Medicine and the Journal of the American College of Cardiology.
“Dr. Steinberg is recognized by his peers as a key opinion leader in cardiology focusing on rhythm management. We are excited to have him join our Clinical Advisory Board,” said Dr. Geoff Houlton, President, CEO and Chief Medical Officer of Heart Force Medical. “His insight will greatly assist Heart Force to bring the dBG® to the forefront of cardiovascular clinical practice.”
“I am pleased to be joining Heart Force’s Clinical Advisory Board. Heart Force’s initial clinical results are impressive,” said Dr. Jonathan Steinberg. “The ability for the dBG® to provide a non-invasive, predictive assessment of left ventricular pressure and its first derivative (LVdP/dtmax) will have multiple uses for future clinical care and medical outcomes.”
About Heart Force:
Heart Force Medical Inc. (HFM), a private company, has invented and holds patents for the digital Ballistocardiograph (dBG). The dBG 300, a non-invasive, standalone, portable unit, which is already approved in the United States, Europe and Canada, captures the movement (acceleration and force) of each heart beat. Preliminary evaluation has determined that a 10-30 second recording of the dBG waveform is sufficient for a detailed analysis of cardiac performance.
SOURCE Heart Force Medical Inc.
